PortfoliosLab logoPortfoliosLab logo
ELAN vs. EMN
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ELAN vs. EMN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elanco Animal Health Incorporated (ELAN) and Eastman Chemical Company (EMN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ELAN vs. EMN - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ELAN
Elanco Animal Health Incorporated
2.17%86.87%-18.72%21.93%-56.94%-7.47%4.14%-6.60%-12.42%
EMN
Eastman Chemical Company
20.20%-26.87%5.11%14.66%-30.38%23.54%31.78%12.01%-26.11%

Fundamentals

Market Cap

ELAN:

$11.49B

EMN:

$8.71B

EPS

ELAN:

-$0.47

EMN:

$4.10

PS Ratio

ELAN:

2.44

EMN:

1.00

PB Ratio

ELAN:

1.75

EMN:

1.46

Total Revenue (TTM)

ELAN:

$4.72B

EMN:

$8.75B

Gross Profit (TTM)

ELAN:

$2.59B

EMN:

$1.84B

EBITDA (TTM)

ELAN:

$874.00M

EMN:

$1.30B

Returns By Period

In the year-to-date period, ELAN achieves a 2.17% return, which is significantly lower than EMN's 20.20% return.


ELAN

1D
-3.38%
1M
-11.38%
YTD
2.17%
6M
11.15%
1Y
123.38%
3Y*
34.99%
5Y*
-4.29%
10Y*

EMN

1D
-0.67%
1M
1.92%
YTD
20.20%
6M
25.44%
1Y
-9.70%
3Y*
0.42%
5Y*
-3.98%
10Y*
3.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ELAN vs. EMN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELAN
ELAN Risk / Return Rank: 9494
Overall Rank
ELAN Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
ELAN Sortino Ratio Rank: 9595
Sortino Ratio Rank
ELAN Omega Ratio Rank: 9393
Omega Ratio Rank
ELAN Calmar Ratio Rank: 9393
Calmar Ratio Rank
ELAN Martin Ratio Rank: 9696
Martin Ratio Rank

EMN
EMN Risk / Return Rank: 3030
Overall Rank
EMN Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
EMN Sortino Ratio Rank: 2929
Sortino Ratio Rank
EMN Omega Ratio Rank: 2828
Omega Ratio Rank
EMN Calmar Ratio Rank: 3232
Calmar Ratio Rank
EMN Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELAN vs. EMN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and Eastman Chemical Company (EMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ELANEMNDifference

Sharpe ratio

Return per unit of total volatility

2.44

-0.23

+2.67

Sortino ratio

Return per unit of downside risk

3.55

-0.03

+3.58

Omega ratio

Gain probability vs. loss probability

1.45

1.00

+0.46

Calmar ratio

Return relative to maximum drawdown

4.85

-0.28

+5.13

Martin ratio

Return relative to average drawdown

18.09

-0.48

+18.57

ELAN vs. EMN - Sharpe Ratio Comparison

The current ELAN Sharpe Ratio is 2.44, which is higher than the EMN Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of ELAN and EMN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ELANEMNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.44

-0.23

+2.67

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.10

-0.13

+0.03

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.12

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.13

0.23

-0.36

Correlation

The correlation between ELAN and EMN is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

ELAN vs. EMN - Dividend Comparison

ELAN has not paid dividends to shareholders, while EMN's dividend yield for the trailing twelve months is around 4.41%.


TTM20252024202320222021202020192018201720162015
ELAN
Elanco Animal Health Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EMN
Eastman Chemical Company
4.41%5.22%3.57%3.54%3.77%2.34%2.66%3.18%3.15%2.26%2.51%2.46%

Drawdowns

ELAN vs. EMN - Drawdown Comparison

The maximum ELAN drawdown since its inception was -78.00%, roughly equal to the maximum EMN drawdown of -76.11%. Use the drawdown chart below to compare losses from any high point for ELAN and EMN.


Loading graphics...

Drawdown Indicators


ELANEMNDifference

Max Drawdown

Largest peak-to-trough decline

-78.00%

-76.11%

-1.89%

Max Drawdown (1Y)

Largest decline over 1 year

-24.79%

-34.67%

+9.88%

Max Drawdown (5Y)

Largest decline over 5 years

-78.00%

-49.35%

-28.65%

Max Drawdown (10Y)

Largest decline over 10 years

-62.74%

Current Drawdown

Current decline from peak

-37.04%

-30.16%

-6.88%

Average Drawdown

Average peak-to-trough decline

-39.85%

-19.06%

-20.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.64%

20.38%

-13.74%

Volatility

ELAN vs. EMN - Volatility Comparison

Elanco Animal Health Incorporated (ELAN) has a higher volatility of 14.32% compared to Eastman Chemical Company (EMN) at 12.18%. This indicates that ELAN's price experiences larger fluctuations and is considered to be riskier than EMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ELANEMNDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.32%

12.18%

+2.14%

Volatility (6M)

Calculated over the trailing 6-month period

25.77%

25.39%

+0.38%

Volatility (1Y)

Calculated over the trailing 1-year period

50.81%

42.73%

+8.08%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.55%

31.97%

+12.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

43.81%

31.67%

+12.14%

Financials

ELAN vs. EMN - Financials Comparison

This section allows you to compare key financial metrics between Elanco Animal Health Incorporated and Eastman Chemical Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B1.50B2.00B2.50BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
1.14B
1.97B
(ELAN) Total Revenue
(EMN) Total Revenue
Values in USD except per share items

ELAN vs. EMN - Profitability Comparison

The chart below illustrates the profitability comparison between Elanco Animal Health Incorporated and Eastman Chemical Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
74.6%
17.1%
Portfolio components
ELAN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Elanco Animal Health Incorporated reported a gross profit of 853.00M and revenue of 1.14B. Therefore, the gross margin over that period was 74.6%.

EMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eastman Chemical Company reported a gross profit of 338.00M and revenue of 1.97B. Therefore, the gross margin over that period was 17.1%.

ELAN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Elanco Animal Health Incorporated reported an operating income of 562.00M and revenue of 1.14B, resulting in an operating margin of 49.1%.

EMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eastman Chemical Company reported an operating income of 121.00M and revenue of 1.97B, resulting in an operating margin of 6.1%.

ELAN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Elanco Animal Health Incorporated reported a net income of -276.00M and revenue of 1.14B, resulting in a net margin of -24.1%.

EMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eastman Chemical Company reported a net income of 105.00M and revenue of 1.97B, resulting in a net margin of 5.3%.